<DOC>
	<DOCNO>NCT00914589</DOCNO>
	<brief_summary>This trial conduct Canada , Asia , Europe USA . The aim clinical trial investigate effect safety rFXIII transfusion need patient undergo heart surgery .</brief_summary>
	<brief_title>Multi-national Study Investigating Effect Safety rFXIII Transfusion Needs Patients Undergoing Heart Surgery</brief_title>
	<detailed_description />
	<mesh_term>Blood Coagulation Disorders</mesh_term>
	<mesh_term>Hemostatic Disorders</mesh_term>
	<criteria>Planned coronary artery bypass grafting ( CABG ) CABG plus single heart valve replacement/repair plan replacement/repair single heart valve Known intolerance protamine Known suspect allergy use antifibrinolytic agent Refusal receive blood blood product Planned surgery include aortic arch and/or descend aorta Planned surgery include implantable ventricular assist device Adult congenital heart diseases Two previous cardiac surgery procedures Any know autoimmune disease : Collagen vascular disease ( Systemic lupus erythematosus , Rheumatoid arthritis , Sj√∂grens syndrome ) Endocrine : hyperthyroidism ( Graves disease ) , adrenal insufficiency , Hashimoto 's thyroiditis Neurologic : Multiple sclerosis , myasthenia gravis Skin : pemphigous vulgaris Hematologic : Pernicious anaemia , Autoimmune haemolytic anaemia Vasculitis Primary secondary antiphospholipid syndrome Weight 140 kg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>